Navigation Links
MicroConstants China Signs Site Management Organization Agreement with the Clinical Research Center of No. 307 Hospital

BEIJING, Jan. 28, 2013 /PRNewswire/ -- MicroConstants China Inc., a Contract Research Organization (CRO) conducting preclinical pharmacokinetic studies, early-stage clinical trials, and regulated bioanalysis in China, has signed a strategic collaboration agreement with the clinical research center of the No. 307 Hospital of People's Liberation Army to provide site management services. The agreement designates MicroConstants China as No. 307 Hospital's official site management organization (SMO).

Over the past three years, MicroConstants China has worked closely with the Phase I unit of No. 307 Hospital to implement quality systems and procedures that comply with International Conference on Harmonization Good Clinical Practice (ICH GCP) guidelines. This has included developing standard operating procedures (SOP), training clinical site personnel, performing quality assurance (QA) audits, installing a clinical trial information management system (CTIMS), and obtaining SIDCER Recognition from the Forum for Ethical Review Committees in the Asian and Western Pacific Region (FERCAP).

"Through our collaboration with MicroConstants China, we have learned the true meaning of GCP compliance in daily practice and are now capable of identifying deficiencies and coming up with corrective actions to address them," said Dr. Zeyuan Liu , director of the clinical pharmacology unit at No. 307 Hospital. "Working with MicroConstants China enabled us to improve our quality system in a short period of time and effectively win contracts from major global pharmaceutical companies."

"The execution of this strategic collaboration agreement verifies our achievements and is an important step for our SMO business," said Dr. Q. David Yang , chief executive officer of MicroConstants China. "Our goal is to implement ICH GCP compliant quality systems for more clinical trial centers in China so their clinical trial data can be submitted directly to the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for approval."

About the No. 307 Hospital Clinical Research Center
Established in 1957, the No. 307 Hospital of People's Liberation Army is among the top tier hospitals in China with 38 specialty groups and over 1,100 beds. Their clinical trial center is certified by the SFDA for Phase I clinical studies and Phase II/III/IV clinical studies for cancer, hematology, anti-radiation, detoxification, and anti-dependency drugs. The clinical research center has conducted clinical trials for more than 200 sponsors, including eight of the top ten global pharmaceutical companies.

About MicroConstants China Inc.
MicroConstants China Inc. is a Contract Research Organization (CRO) that was established in 2007 by the founder and president of MicroConstants, Inc., a bioanalytical and DMPK specialty CRO in San Diego, California with over a decade of GLP compliance history. Located in Beijing, MicroConstants China conducts preclinical and clinical pharmacokinetic studies, provides regulated bioanalysis and analytical services, and offers early-stage clinical trial management services and quality system consulting. For more information, please visit

SOURCE MicroConstants China Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. China Botanic Appoints Jack Zhao as Independent Director
2. Dental Radiology Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
3. Dental Lasers Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
4. Respiratory Disposables Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
5. The 1st China International Dental CAD/CAM Forum to Be Held in DenTech China 2013
6. Perceptive Informatics Opens First Customer Care Office in China
7. Affluence, an Aging Population, and Anticipated Rx-to-OTC Switches Boost a Healthy $32 Billion OTC Market in China, According to Kline
8. Government Investments in Upgrades Sustain Laboratory Analytical Instrumentation Market in China, Finds Frost & Sullivan
9. Medical Device Market Updates: IVD and Ophthalmic Devices Dominate Chinas $30.5 bn Medical Device Market; Invisible Hearing Aids Set to Make Big Noise
10. Sihuan Pharmaceutical Collaborates with NeuroVive to Develop Two Innovative Cardio-cerebral Vascular Products in China
11. DenTech China 2012 Closed with Success
Post Your Comments:
(Date:10/12/2017)... 12, 2017   Divoti USA will engrave ... the standard of the latest FDA requirements, which stipulates new criteria ... Anyone in need of Medical ID jewelry such as Medical ID ... are engraved in terms of the new FDA requirements . ... Divoti offers this dark mark ...
(Date:10/11/2017)... 11, 2017  True Health, a leader in ... effort during National Breast Cancer Awareness month to ... Research recently ... that more than 10 million American women are ... BRCA1 or BRCA2 and have not had testing. These ...
(Date:10/7/2017)... 2017   Provista, a proven leader in ... in purchasing power, today announced a new resource area ... Newsroom is the online home for case studies, ... bios, news releases, slideshows and events. ... of resources at their fingertips, viewers can also watch ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... in the greater Dallas, Miami, and Raleigh regions, is organizing an extended charity ... a rare and deadly chromosome abnormality. , After struggling since birth with several ...
(Date:10/13/2017)... ... ... As health professionals work to improve their approach to healthcare, there is a ... filling out a survey; in many cases health professionals and patients are working together ... research on the importance of active engagement with patients and members of the public ...
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's ... President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. ... 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the role ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... PurhealthRX ... CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will ... and providing a CBD form that can be easily incorporated into liquid products, while ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Lori R. ... a member of ElderCounsel, a national organization of elder law and special needs planning ... laws and rules. It also provides a forum to network with elder law attorneys ...
Breaking Medicine News(10 mins):